A disease that needs advertising

How generic Requip may lead to the extinction of restless legs syndrome:

Last week, the drug agency approved the first generic versions of ropinirole tablets for four manufacturers. The move is likely to send Requip sales and advertising plummeting, industry experts predicted.

At least one sleep disorder specialist expects the focus on restless legs syndrome to fade as rapidly as the Requip television commercials “” which have already been pulled from the airwaves.

View 4 Comments >

Join 150,000+ subscribers

Get the best of KevinMD in your inbox

Sign me up! It's free. 
close-link
✓ Join 150,000+ subscribers 
✓ Get KevinMD's 5 most popular stories
Subscribe. It's free.